(Q45405807)

English

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

scientific article published in March 2007

Statements

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. (English)
0 references
Ronald Mitsuyasu
Rebecca Gelman
Deborah Weng Cherng
Alan Landay
John Fahey
Richard Reichman
Alejo Erice
R Pat Bucy
J Michael Kilby
Michael M Lederman
Carol D Hamilton
Juan Lertora
Becky L White
Anne-Marie Duliege
Richard B Pollard
AIDS Clinical Trials Group 328 Study Team
1 March 2007
597-605

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit